These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28031563)

  • 1. Prostate cancer: Risk factors - you find what you are looking for.
    Wallis CJ; Satkunasivam R
    Nat Rev Urol; 2017 Apr; 14(4):202-204. PubMed ID: 28031563
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen screening for prostate cancer in males older than 75 years.
    Luján M; Páez Á
    Med Clin (Barc); 2019 Mar; 152(6):237-240. PubMed ID: 30220470
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing localized prostate cancer in the era of prostate-specific antigen screening.
    Brooks JD
    Cancer; 2013 Nov; 119(22):3906-9. PubMed ID: 24006273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.
    McKenzie PR; Delahunt B; Kench JG; Ross B; Lam Q; deVoss K; Tran HA; Sikaris KA
    Pathology; 2013 Jun; 45(4):343-5. PubMed ID: 23619589
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer: ADT after radical prostatectomy - when and how?
    Stone L
    Nat Rev Urol; 2016 Jul; 13(7):367. PubMed ID: 27215428
    [No Abstract]   [Full Text] [Related]  

  • 6. First, do no harm.
    Pimlott N
    Can Fam Physician; 2012 Sep; 58(9):915. PubMed ID: 22972717
    [No Abstract]   [Full Text] [Related]  

  • 7. US guideline may have led to drop in PSA testing among primary care physicians, studies find.
    McCarthy M
    BMJ; 2015 May; 350():h2906. PubMed ID: 26021822
    [No Abstract]   [Full Text] [Related]  

  • 8. Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries.
    Mittakanti HR; Thomas IC; Shelton JB; Makarov DV; Skolarus TA; Cooperberg MR; Chung BI; Sonn GA; Brooks JD; Leppert JT
    J Clin Oncol; 2016 Oct; 34(29):3586-3587. PubMed ID: 27458297
    [No Abstract]   [Full Text] [Related]  

  • 9. The dilemmas of prostate cancer screening.
    Hugosson J; Carlsson SV
    Med J Aust; 2013 Jun; 198(10):528-9. PubMed ID: 23725256
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis.
    Siegel C
    J Urol; 2015 Aug; 194(2):395. PubMed ID: 26195367
    [No Abstract]   [Full Text] [Related]  

  • 11. Should we screen for prostate cancer? A re-examination of the evidence.
    Del Mar CB; Glasziou PP; Hirst GH; Wright RG; Hoffmann TC
    Med J Aust; 2013 Jun; 198(10):525-7. PubMed ID: 23725255
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer risk calculators using ERSPC-derived data underestimate the risk if the WHO IRP 96/670 standard is used in prostate-specific antigen analysis.
    Tormey WP
    Eur Urol; 2015 Sep; 68(3):541-2. PubMed ID: 25819721
    [No Abstract]   [Full Text] [Related]  

  • 13. Baseline PSA testing for men in their 40s: currently available evidence strongly supports baseline PSA measurements in this age group.
    Catalona WJ
    Oncology (Williston Park); 2014 Feb; 28(2):154, 156. PubMed ID: 24701705
    [No Abstract]   [Full Text] [Related]  

  • 14. Valentine's Day PSA.
    Dasgupta P
    BJU Int; 2014 Feb; 113(2):177. PubMed ID: 24712694
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer screening can save lives but it is too early for a national programme, study finds.
    Sayburn A
    BMJ; 2014 Aug; 349():g5055. PubMed ID: 25102993
    [No Abstract]   [Full Text] [Related]  

  • 16. What is a "Diagnostic Test Reference Range" Good for?
    Habibzadeh P; Yadollahie M; Habibzadeh F
    Eur Urol; 2017 Nov; 72(5):859-860. PubMed ID: 28558944
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations.
    Loeb S
    BJU Int; 2015 Apr; 115(4):500. PubMed ID: 25808708
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate Cancer Invading the Rectum Misdiagnosed as Rectal Cancer.
    Sui X; Fu JX; Wang XJ
    Am J Med Sci; 2021 Feb; 361(2):e17-e18. PubMed ID: 32951845
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.
    Zavaski ME; Meyer CP; Sammon JD; Hanske J; Gupta S; Sun M; Trinh QD
    JAMA Intern Med; 2016 Apr; 176(4):546-7. PubMed ID: 26857148
    [No Abstract]   [Full Text] [Related]  

  • 20. Population pharmacokinetic-pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin.
    Snelder N; Drenth HJ; Riber Bergmann K; Wood ND; Hibberd M; Scott G
    Br J Clin Pharmacol; 2019 Jun; 85(6):1247-1259. PubMed ID: 30731514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.